Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15941837.
- Also identified by PMC identifier 1797984.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Treatment of pain in rheumatoid arthritis must take into account the gastrointestinal and cardiovascular risk of individual patients. Adequate results are not yet available, and until they are, treatment recommendations must take into account, not only the more favourable gastrointestinal risk profile of selective COX-2 inhibitors, but also the potential atherothrombotic risk of any NSAID or selective COX-2 inhibitor treatment.
Medical subject headings
- Anti-Inflammatory Agents, Non-Steroidal
- Atherosclerosis
- Thrombosis